CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Recruiting · NCT06949800 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | High-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, human papillomavirus-related squamous cell carcinoma | Recruiting | Phase 2 | 2026-09-15 | NCT06949800 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Exegi Pharma, LLC | 3 |
| National Cancer Institute (NCI) | 3015 |
| University of California, San Francisco | 637 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Puerto Rico Comprehensive Cancer Center | San Juan | Puerto Rico | 1 |